Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
4,033.60
4,433.50
4,335.21
4,086.54
4,147.90
4,766.60
4,381.60
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,033.60
4,433.50
4,335.21
4,086.54
4,147.90
4,766.60
4,381.60
Raw Material Cost
2,716.27
2,996.07
2,925.11
2,791.76
2,791.26
3,275.86
3,027.96
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
26.23
28.91
34.10
32.65
32.24
34.24
36.78
Selling and Distribution Expenses
1,172.55
1,171.70
1,250.97
1,208.82
1,176.24
1,240.03
1,419.02
Other Expenses
-2.42
-2.81
-3.25
-3.14
-2.70
-3.17
-3.51
Total Expenditure (Excl Depreciation)
3,890.85
4,168.58
4,177.65
4,001.88
3,972.71
4,518.40
4,448.71
Operating Profit (PBDIT) excl Other Income
142.79999999999998
264.9
157.6
84.7
175.2
248.2
-67.1
Other Income
33.83
32.01
23.37
27.05
26.50
27.75
19.74
Operating Profit (PBDIT)
470.35
578.22
436.36
425.18
513.12
600.32
297.99
Interest
26.23
28.91
34.10
32.65
32.24
34.24
36.78
Exceptional Items
0.91
0.95
1.06
1.04
0.00
0.00
-26.77
Gross Profit (PBDT)
1,317.33
1,437.43
1,410.10
1,294.77
1,356.64
1,490.74
1,353.64
Depreciation
323.36
323.36
351.37
351.37
360.42
360.42
389.89
Profit Before Tax
121.68
226.89
51.96
42.19
120.45
205.66
-155.47
Tax
37.59
47.31
52.23
19.51
24.03
39.11
35.72
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
81.04
175.81
-5.16
18.94
89.58
160.07
-178.37
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
81.04
175.81
-5.16
18.94
89.58
160.07
-178.37
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.86
2.02
-3.09
2.40
4.77
4.19
-18.01
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
83.90
177.83
-8.25
21.34
94.35
164.26
-196.38
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
7,445.89
7,479.36
7,303.47
7,317.08
7,418.68
7,501.08
7,491.01
Earnings per share (EPS)
0.14
0.31
-0.01
0.03
0.16
0.28
-0.3
Diluted Earnings per share
0.14
0.31
-0.01
0.03
0.16
0.28
-0.3
Operating Profit Margin (Excl OI)
2.81%
5.03%
1.42%
1.14%
3.04%
4.45%
-2.55%
Gross Profit Margin
11.03%
12.41%
9.3%
9.63%
11.59%
11.88%
5.35%
PAT Margin
2.01%
3.97%
-0.12%
0.46%
2.16%
3.36%
-4.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is -2.76% vs -1.11% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is -11.12% vs 100.85% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is -10.30% vs 20.18% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is -18.63% vs -11.78% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Compare Quarterly Results Of Yixintang Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
4,033.60
0
4,033.60
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,033.60
0
4,033.60
Raw Material Cost
2,716.27
0
2,716.27
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
26.23
0
26.23
Selling and Distribution Expenses
1,172.55
0
1,172.55
Other Expenses
-2.42
0.00
-2.42
Total Expenditure (Excl Depreciation)
3,890.85
0
3,890.85
Operating Profit (PBDIT) excl Other Income
142.76
0.00
142.76
Other Income
33.83
0
33.83
Operating Profit (PBDIT)
470.35
0
470.35
Interest
26.23
0
26.23
Exceptional Items
0.91
0
0.91
Gross Profit (PBDT)
1,317.33
0
1,317.33
Depreciation
323.36
0
323.36
Profit Before Tax
121.68
0
121.68
Tax
37.59
0
37.59
Provisions and contingencies
0
0
0.00
Profit After Tax
81.04
0
81.04
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
81.04
0
81.04
Share in Profit of Associates
0
0
0.00
Minority Interest
2.86
0
2.86
Other related items
0.00
0.00
0.00
Consolidated Net Profit
83.90
0
83.90
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
7,445.89
0
7,445.89
Earnings per share (EPS)
0.14
0
0.14
Diluted Earnings per share
0.14
0
0.14
Operating Profit Margin (Excl OI)
2.81%
0%
0.00
2.81%
Gross Profit Margin
11.03%
0%
0.00
11.03%
PAT Margin
2.01%
0%
0.00
2.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 403.36 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -9.02% vs 2.27% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -2.76% vs -1.11% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.39 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -52.81% vs 2,268.29% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -11.12% vs 100.85% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 43.65 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -20.08% vs 32.25% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -10.30% vs 20.18% in Jun 2025
Quarterly - Interest
Interest 2.62 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -9.34% vs -15.25% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -18.63% vs -11.78% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.81%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025
Footer loading
